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1. Introduction 
In spectrophotometric analysis a source of radiation is used that extend into the ultraviolet region of the spectrum. 
The kind and amount of radiation absorbed by a molecule depend upon the structure of the molecule, the amount of 
radiation absorbed also depend upon the number of molecules interacting with the radiation. The study of these 
dependencies is called absorption spectroscopy. 
The multicomponent formulations have gained a lot of importance now a day due to greater patient acceptability, 
increased potency and decreased side effects. The quantitative analysis of such multicomponent formulations is very 
important. One of the quantitative procedures for multicomponent formulations is the simultaneous spectrophotometric 
method, which utilizes the measurement of intensity of electromagnetic radiation emitted or absorbed by the analyte.  
Vierodt’s method:  
If the sample contain two absorbing drugs each of which absorb at λmax of the other, it may be possible to 
determine both drugs by Vierodt’s method. Simultaneous estimation of two drugs can be possible only when λmax of both 
drug components are reasonably dissimilar and two components do not interact chemically. It is calculated by formula, 
𝐶𝑝𝑟𝑜 =
𝐴2𝑎𝑦1−𝐴1𝑎𝑦2
𝑎𝑥2𝑎𝑦1−𝑎𝑥1𝑎𝑦2
……………………. (1) 
 
𝐶𝑟𝑜𝑠 =
𝐴1𝑎𝑥2−𝐴2𝑎𝑥1
𝑎𝑥2𝑎𝑦1−𝑎𝑥1𝑎𝑦2
……………………. (2) 
Whereas, 
ax1 and ax2 are absorptivities of PRO at λ1 and λ2 respectively. 
ay1 and ay2 are absorptivities of ROS at λ1 and λ2 respectively.  
             A1 an A2 are absorbance of sample at λ1 and λ2 respectively. 
Absorbance ratio method 
It is modification of simultaneous equation method. It is based on the principle that for the substance which obeys 
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Beer’s law at all wavelength, the ratio of absorbances at any two wavelengths is a constant value independent of 
concentration or pathlength. It is also called as isoabsorptive point method or Q method. 
In absorbance ratio method, absorbances are measured at two wavelengths one being the λmax of one of the 
component and other being wavelength of equal absorptivity of the two components. It is calculated by formula given 
below, 
𝐶𝑃𝑅𝑂 =
𝑄𝑚−𝑄𝑦
𝑄𝑥−𝑄𝑦
×
𝐴
𝑎𝑥1
………………….. (3) 
 
𝐶𝑅𝑂𝑆 =
𝑄𝑚−𝑄𝑥
𝑄𝑦−𝑄𝑥
×
𝐴
𝑎𝑥2
……………….…. (4) 
Whereas, 
CPRO- Concentration of propranolol hydrochloride 
CROS- Concentration of rosuvastatin calcium 
A-Absorbance of sample at isoabsorptive wavelength 
Ax1 and Ax2- Absorptivity of PRO and ROS at isoabsorptive point respectively. 
𝑄𝑚 =
𝐴𝑏𝑠𝑜𝑟𝑏𝑎𝑛𝑐𝑜𝑓𝑠𝑎𝑚𝑝𝑙𝑒𝑎𝑡 λmax 𝑜𝑓𝑜𝑛𝑜𝑓𝑡𝑕𝑒𝑐𝑜𝑚𝑝𝑜𝑛𝑒𝑛𝑡(𝜆2)
𝐴𝑏𝑠𝑜𝑏𝑎𝑛𝑐𝑒𝑜𝑓𝑠𝑎𝑚𝑝𝑙𝑒𝑎𝑡𝑖𝑠𝑜𝑎𝑏𝑠𝑜𝑟𝑝𝑡𝑖𝑣𝑒𝑤𝑎𝑣𝑒𝑙𝑒𝑛𝑔𝑡𝑕
 
𝑄𝑃𝑅𝑂 =
𝐴𝑏𝑠𝑜𝑟𝑝𝑡𝑖𝑣𝑖𝑡𝑦𝑜𝑓𝑃𝑅𝑂𝑎𝑡 λmax 𝑜𝑓𝑜𝑛𝑜𝑓𝑡𝑕𝑒𝑐𝑜𝑚𝑝𝑜𝑛𝑒𝑛𝑡(𝜆2)
𝐴𝑏𝑠𝑜𝑟𝑝𝑡𝑖𝑣𝑖𝑡𝑦𝑜𝑓𝑃𝑅𝑂𝑎𝑡𝑖𝑠𝑜𝑎𝑏𝑠𝑜𝑟𝑝𝑡𝑖𝑣𝑒𝑤𝑎𝑣𝑒𝑙𝑒𝑛𝑔𝑡𝑕
 
𝑄𝑅𝑂𝑆 =
𝐴𝑏𝑠𝑜𝑟𝑝𝑡𝑖𝑣𝑖𝑡𝑦𝑜𝑓𝑅𝑂𝑆𝑎𝑡 λmax 𝑜𝑓𝑜𝑛𝑜𝑓𝑡𝑕𝑒𝑐𝑜𝑚𝑝𝑜𝑛𝑒𝑛𝑡(𝜆2)
𝐴𝑏𝑠𝑜𝑟𝑝𝑡𝑖𝑣𝑖𝑡𝑦𝑜𝑓𝑅𝑂𝑆𝑎𝑡𝑖𝑠𝑜𝑎𝑏𝑠𝑜𝑟𝑝𝑡𝑖𝑣𝑒𝑤𝑎𝑣𝑒𝑙𝑒𝑛𝑔𝑡 𝑕
 
 Propranolol hydrochloride is non-selective beta-adrenergic receptor blocking agent. Propranolol hydrochloride 
competitively blocks beta-adrenergic receptor and gives membrane-stabilizing action. It is stable, white crystalline solid 
readily soluble in water and ethanol and methanol.  
OCH2CHOHCH2NHCH(CH3)2 . HCl
2-Propranol,1-[(1-methylethyl)amino]-3-(1-napthalenyloxy)-hydrochloride  
 Rosuvastatin calcium is a synthetic lipid-lowering agent.  Rosuvastatin is aninhibitor of 3-
hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase.  This enzymecatalyzes the conversion of HMG-CoA to 
mevalonate, an early and rate-limiting step incholesterol biosynthesis. Rosuvastatin calcium is a white amorphous powder 
that is sparingly soluble in water and methanol, and slightly soluble in ethanol. Rosuvastatin is a hydrophilic compound 
with a partition coefficient (octanol/water) of 0.13 at pH of 7.0. 
N
NN
SO2Me
O-
OH
OH O
F
Ca2+
Bis[(E)-7-[4-(flurophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]
pyrimidin-5-yl]-(3R,5S)-3-5-dihydroxyhept-6-enoic acid] calcium salt
2
 
 At present no any UV spectrophotometric method was reported in literature for quantitative estimation of 
propranolol hydrochloride and rosuvastatin calcium. Hence, attempt was made to develop simple, precise and accurate UV 
spectrophotometric method for simultaneous estimation of both the drugs by simultaneous equation (Vierodt’s method) and 
absorbance ratio (Q- point) method. Further, method were validated for accuracy, precision, LOD, LOQ as per ICH 
guidelines. 
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2. Material and method 
 Propranolol hydrochloride and rosuvastatin calcium was obtained as a gift sample from Watson pharma, Mumbai 
and Okasa pharma, Satara (MH) respectively. Methanol of analytical reagent was selected as common solvent for method 
development. UV visible spectrophotometer (Shimadzu, Japan) with 1 cm quartz cells was used in present investigation for 
absorbance measurement. 
2.1 Calibration curve of propranolol hydrochloride and rosuvastatin calcium: 
 100 mg of propranolol hydrochloride and rosuvastatin calcium was dissolved separately in 100 ml volumetric flask 
containing methanol as solvent to form stock solution having strength 1000 µg/ml. From that, 10 ml of solution was 
withdrawn and diluted upto 100 ml to give stock solution having strength 100 µg/ml and using this stock solution various 
concentrations were prepared in the range 2-40 µg/ml. firstly λmax of both the drug was determined using concentration 10 
µg/ml. Then absorbances of both the drugs were determined using UV spectrophotometer at the irrespective λ max. 
2.2 Determination of isoabsorptive point for propranolol hydrochloride and rosuvastatin calcium: 
 For simultaneous estimation of propranolol hydrochloride and rosuvastatin calcium in pure and pharmaceutical 
dosage form by absorbance ratio method it was necessary to determine isoabsorptive point in which both drugs showed 
absorption at particular wavelength. It can be determined spectrophotometrically by preparing various concentrations in 
beers range of both pure drugs and obtaining overlay spectra. 
2.3 Procedure for estimation of drug in pharmaceutical dosage form: 
 Rectangular (2*3 cm) gastroretentive bilayer floating film containing 5 mg of rosuvastatin calcium and 40 mg of 
propranolol hydrochloride was dissolved in 100 ml volumetric flask containing methanol as solvent with stirring and kept 
aside for 6-8 hours. Further dilutions were prepared so that concentration of the sample solution will be in the Beers range 
of respective drugs. 
 
3. Result and discussion 
 Propranolol hydrochloride and rosuvastatin calcium showed λmax at 289 nm and 243 nm respectively. Linearity 
was found in the range 2-42 µg/ml with correlation coefficient (r) 0.9984 for propranolol hydrochloride and 2-40 µg/ml 
with correlation coefficient (r) 0.9996 for rosuvastatin calcium. Absorptivity values are calculated by preparing multiple 
dilutions of 10 µg/ml solution of both pure drug and taking average mean of the same. To evaluate the validity and 
reproducibility of the method known amount of pure drug was added to the analysed sample of film and mixture was 
analysed for the drug content using proposed method. The recovery experiments indicated the absence of interference from 
the commonly encountered pharmaceutical additive and excipients. 
Figure 1: λmax of a) propranolol hydrochloride (289 nm), b) rosuvastatin calcium (243 nm) and c) isoabsorptive 
point (277 nm) 
  
                                   a                                                            b                                                              c 
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Figure 2: overlay spectra of a) propranolol hydrochloride (289nm) and b) rosuvastatin calcium (243nm) 
 
a                                                                           b 
 
Table 1: Calibration curve of propranolol hydrochloride and rosuvastatin calcium 
Propranolol hydrochloride (289nm) Rosuvastatin calcium (243nm) 
Concentration 
(µg/ml) 
Absorbance 
(Mean±SD) 
SE 
(n=3) 
Concentration 
(µg/ml) 
Absorbance 
(Mean±SD) 
SE 
(n=3) 
10 0.1484±0.002 0.0011 12 0.4117±0.0002 0.0001 
12 0.1734±0.004 0.0026 16 0.5678±0.0002 0.0001 
14 0.2686±0.000 0.0004 20 0.7331±0.0003 0.0001 
16 0.2899±0.003 0.0017 24 0.9052±0.0003 0.0001 
018 0.3244±0.006 0.0039 28 1.0540±0.0032 0.0018 
20 0.3495±0.008 0.0050 32 1.2000±0.0100 0.0057 
 
Regression equation Y= Mx+C Regression equation Y= Mx+C 
Beers law limit 2-42 µg/ml Beers law limit 2-40 µg/ml 
Slope  0.03857 Slope  0.039801 
Intercept -0.03892 Intercept -0.06366 
Correlation  0.99840  Correlation  0.99962  
Sandell’s sensitivity 0.043744 Sandell’s sensitivity 0.026427 
  
Table 2: Absorptivity values for propranolol hydrochloride and rosuvastatin calcium at respective λmax and 
isoabsorptive point 
 Absorptivity of propranolol hydrochloride Absorptivity of rosuvastatin calcium 
289 nm 243 nm 277 nm 243 nm 277 nm 289 nm 
Mean (n=3) 228.6 298.8 146.3 378.3 141.1 103.0 
± SD 1.000 0.5859 1.237 1.336 1.311 1.261 
SE 0.5774 0.3383 0.7113 0.7713 0.7572 0.7278 
 
Table 3: Analysis of bilayer film formulation 
Film component Labelled claim (mg) Amount found (mg) % purity± SD 
SE 
(n=3) 
Propranolol hydrochloride 40 39.492 98.73±0.05937 0.03428 
Rosuvastatin calcium 05 4.877 97.54±0.05508 0.03180 
 
Table 4: Statistical evaluation of precision 
Drug Film 
strength 
Interday precision Intraday precision 
Mean ± SD SE Mean ± SD SE (n=3) 
Propranolol 
hydrochloride 
40 mg 39.16 0.4359 0.2517 0.3972 0.07638 0.04410 
20 mg 19.50 0.2574 0.1486 19.35 0.04635 0.02674 
Rosuvastatin 
calcium 
05 mg 4.77 0.1000 0.05773 4.877 0.06807 0.03930 
10 mg 9.723 0.1343 0.07753 9.870 0.05000 0.02887 
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Table 5: data of validation parameters 
 
Parameters 
Observed values 
Propranolol 
hydrochloride 
Rosuvastatin 
calcium 
Linearity (r) 0.99840 0.99962 
Accuracy (% recovery) 98.73 97.54 
LOD (µg/ml) 0.3279 0.1961 
LOQ (µg/ml) 0.9937 0.5944 
 
4. Conclusion 
 Simultaneous equation (Vierodt’s method) and absorbance ratio method were found to be simple, precise and 
accurate. Statistical analysis of the results has been carried out revealing high accuracy and good precision. The developed 
methods can be used in routine analysis of propranolol hydrochloride and rosuvastatin calcium in bulk and combined 
pharmaceutical dosage forms.  
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